Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Hao Hui Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4339-3441; OpenAlex author ID A5100353663. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers

Papers 7

  1. Development and validation of a nomogram for a prognostic model for resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hbpd.2025.04.005↗
  2. Update on the global, regional, and national burden of pancreatic cancer: Insights from the Global Burden of Disease 2021 Study. Co-author DOI 10.1097/cm9.0000000000003753↗
  3. M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62. Last author DOI 10.1186/s13062-023-00356-y↗
  4. Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal ad… Last author DOI 10.3389/fimmu.2022.1016647↗
  5. Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy. Co-author DOI 10.3389/fonc.2021.618764↗
  6. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma. First author DOI 10.3892/or.2020.7615↗
  7. Cyr61-positive cancer stem-like cells enhances distal metastases of pancreatic cancer. Co-author DOI 10.18632/oncotarget.12248↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yumin Li · 2 shared papers, 2025 · strength 0.60
  2. Huijuan Cheng · 2 shared papers, 2025 · strength 0.60
  3. Luming Liu · 2 shared papers, 2016–2023 · strength 0.29
  4. Wulin Wang · 2 shared papers, 2020–2021 · strength 0.27
  5. Sheng Wang · 2 shared papers, 2020–2021 · strength 0.27
  6. Chunzhao Yu · 2 shared papers, 2020–2021 · strength 0.27
  7. Tianliang Song · 1 shared paper, 2025 · strength 0.24
  8. Wenzhi Guo · 1 shared paper, 2025 · strength 0.24
  9. Linjia Peng · 1 shared paper, 2023 · strength 0.22
  10. Huifeng Gao · 1 shared paper, 2023 · strength 0.22
  11. Ke Zhang · 1 shared paper, 2023 · strength 0.22
  12. Yunpeng Wang · 1 shared paper, 2022 · strength 0.15
  13. Junge Deng · 1 shared paper, 2022 · strength 0.15
  14. Kaichun Wu · 1 shared paper, 2020 · strength 0.11
  15. Chenyue Zhang · 1 shared paper, 2016 · strength 0.07
  16. Zhen Chen · 1 shared paper, 2016 · strength 0.07
  17. Weidong Shi · 1 shared paper, 2016 · strength 0.07
  18. Zhiqiang Meng · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.